BELLUS Health Inc (BLU)

6.04 -0.06  -0.98% NASDAQ Oct 20, 16:00 6.04 0.00  0.00% After-Hours: 16:09 USD
View Full Chart
Price Chart
View All BLU News

News

View All Events

Events

Date Type Description
11/12/2021 Earnings Results Q3 2021 Earnings Results
08/11/2021 Earnings Results Q2 2021 Earnings Results
05/10/2021 Earnings Results Q1 2021 Earnings Results
05/10/2021 14:00 EST AGM 2020 Annual General Meeting
02/25/2021 Earnings Results Q4 2020 Earnings Results
11/12/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
  • URL: http://www.bellushealth.com
  • Investor Relations URL: https://ir.bellushealth.com
  • HQ State/Province: Quebec
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: Aug. 11, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.